Pretreatment risk factors and importance of comorbidity for overall survival, complete remission, and early death in patients with acute myeloid leukemia

Hematology

Volumn 17, Issue 2, 2012, Pages 53-58

  Djunic, Irena ^a   Virijevic, Marijana ^a   Novkovic, Aleksandra ^b   Djurasinovic, Vladislava ^a   Colovic, Natasa ^a,c   Vidovic, Ana ^a,c   Suvajdzic Vukovic, Nada ^a,c   Tomin, Dragica ^a,c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b Clinical Hospital Center 'Zemun'   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Acute myeloid leukemia; Comorbidity; Risk factors

Indexed keywords

LACTATE DEHYDROGENASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGRESSION; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; KARYOTYPE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFECTION; KARYOTYPE; L-LACTATE DEHYDROGENASE; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTOSIS; MALE; MIDDLE AGED; REMISSION INDUCTION; RISK FACTORS; SERBIA; TREATMENT OUTCOME;

EID: 84862982188     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453312X13221316477651     Document Type: Article

References (24)

1. Jabbour EJ, Estey E, Kantarjian HM. Adult acute myeloid leukemia. Mayo Clin Proc. 2006;81(2):247-260.
2. Deschler B, Lubbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107(9):2099-2107.
3. Erba HP. Prognostic factors in elderly patients with AML and the implications for treatment. Hematol Am Soc Hematol Educ Program. 2007;1:420-428.
4. Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood. 2006;107:3481-3485.
5. Kantarjian H, O'Brien S, Cortes J, Slovak ML, Willman CL, Godwin JE, et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high risk myelodisplastic syndrome: predictive prognostic models for outcome. Cancer. 2006;106:1090-1098.
6. Giles FJ, Borthakur G, Ravandi F, Faderl S, Verstovsek S, Thomas D, et al. The haematopoetic cell transplantation comorbidity index score predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukemia. Br J Haematol. 2007;136:624-627.
7. Grimwade D, Hills RK. Independent prognostic factors for AML outcome. Hematol Am Soc Hematol Educ Program. 2009:385-395.
8. Schellongowski P, Staudinger T, Kundi M, Laczika K, Locker GJ, Bojic A, et al. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center expiriance. Haematologica. 2011;96(2):231-237.
9. Blaise D, Vey N, Faucher C, Mohty M. Current status of reduced intensity conditioning allogenic stem cell transplantation for acute myeloid leukemia. Haematologica. 2007;92(4):533-541.
10. Feinstein AR. The pretherapeutic classification of co-morbidity in chronic disease. J Clin Dis. 1970;23:455-468.
11. Birim O, Kappetein AP, Bogers AJJC. Charlson comorbidity index as a predictor of long term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg. 2005;28:759-762.
12. Sorror ML, Marris MB, Storb R, Fonatsch C, Heinecke A, Wormann B, et al. Hematopoetic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assasment before alogenic HCT. Blood. 2005;106:2912-2919.
13. Hiddeman W, Kern W, Schoch C, Mozziconacci MJ, Arnoulet C, Coso D, et al. Management of acute myeloid leukemia in elderly patients. J Clin Oncol. 1999;17:3569-3576.
14. Etienne A, Esterni B, Charbonnier A, Baron F, Sandmaier BM, Maloney DG, et al. Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia. Cancer. 2007;109: 1376-1383.
15. Malfuson JV, Etienne A, Turlure P, de Revel T, Tomas X, Contentin S, et al. Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia. Haematologica. 2008;93:1806-1813.
16. Cheson BD, Bennet JM, Kopecky KJ, Buchner T, Willman CL, Estey EH, et al. International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcome, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol. 2003; 21:4642-4649.
17. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the acuteleukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976;33:219-228.
18. Donner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:454-474.
19. Kristinsson SY, Derolf AR, Edgren G, Dickman PW, Bjorkkholm M. Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in Sweden. J Clin Oncol. 2009;27(12):2073-2080.
20. Breccia M, Frustaci AM, Cannella L, Stefanizzi C, Latagliata R, Cartoni C, et al. Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in elderly acute myeloid leukemia patients. Haematol Oncol. 2009;27:148-153.
21. Klepin HD, Baldalucci L. Acute myelogenous leukemia in older adults. Onncologist. 2009;14:222-232.
22. Ferrnandez HF. New trends in the standard of care for initial therapy of acute myeloid leukemia. Hematol Am Soc Hematol Educ Program. 2010;2010:56-61.
23. Lowenberg B. Acute myeloid leukemia: the challenge of capturing isease variety. Hematol Am Soc Hematol Educ Program. 2008;1:1-11.
24. Sung L, Lange BJ, Gerbing RB, Alonzo TA, Feusner J. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood. 2007;110(10):3532-3539.